7 things for ASCs to know about the newest COVID-19 booster

The FDA has authorized new bivalent COVID-19 booster shots from Pfizer and Moderna for emergency use for all Americans 12 and over, according to a Sept. 1 report from the Baltimore-based Johns Hopkins Bloomberg School of Public Health. 

Read the full post at Becker's ASC
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive